sodium oxybate – Talk Bio

Actionable Insights Powered by AI

FDA Approves Avadel’s Lumryz for Pediatric Narcolepsy Patients

6 months ago talkbio0Tagged Approved, Avadel, Cataplexy, Daytime Somnolence, Excessive (qualifier value), Excessive Daytime Sleepiness, LUMRYZ, Narcolepsy, Pediatric brand name, sodium oxybate, United States Food and Drug Administration

Avadel Pharmaceuticals, Lumryz, narcolepsy, pediatric patients, FDA approval, sodium oxybate, cataplexy, excessive daytime sleepiness (EDS)

Avadel Pharmaceuticals’ Narcolepsy Drug LUMRYZ Receives FDA Approval and Orphan Drug Exclusivity

7 months ago talkbio0Tagged Approved, Avadel, extended-release, LUMRYZ, Narcolepsy, Oral Suspension, Orphan Drug Exclusivity, sodium oxybate, United States Food and Drug Administration

Avadel Pharmaceuticals, LUMRYZ, narcolepsy, FDA approval, Orphan Drug Exclusivity, sodium oxybate, extended-release oral suspension